Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Read More…
Industry, Sector and Symbol
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Phone49-6172-608-2522
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$19.44 billion
Profitability
Miscellaneous
Employees112,658
Next Earnings Date10/29/2019 (Confirmed)
OptionableOptionable
Fresenius Medical Care AG & Co. (NYSE:FMS) Frequently Asked Questions
What is Fresenius Medical Care AG & Co.'s stock symbol?
Fresenius Medical Care AG & Co. trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."
How often does Fresenius Medical Care AG & Co. pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co.?
Fresenius Medical Care AG & Co. announced an annual dividend on Thursday, May 9th. Investors of record on Monday, May 20th will be paid a dividend of $0.6551 per share on Friday, May 31st. This represents a dividend yield of 1.59%. The ex-dividend date is Friday, May 17th. This is a boost from Fresenius Medical Care AG & Co.'s previous annual dividend of $0.44. View Fresenius Medical Care AG & Co.'s Dividend History.
How were Fresenius Medical Care AG & Co.'s earnings last quarter?
Fresenius Medical Care AG & Co. (NYSE:FMS) released its quarterly earnings results on Tuesday, July, 30th. The company reported $0.52 EPS for the quarter, missing analysts' consensus estimates of $0.55 by $0.03. The firm had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.78 billion. Fresenius Medical Care AG & Co. had a return on equity of 10.18% and a net margin of 7.34%. View Fresenius Medical Care AG & Co.'s Earnings History.
When is Fresenius Medical Care AG & Co.'s next earnings date?
How can I listen to Fresenius Medical Care AG & Co.'s earnings call?
Fresenius Medical Care AG & Co. will be holding an earnings conference call on Tuesday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Fresenius Medical Care AG & Co. issued on next quarter's earnings?
Fresenius Medical Care AG & Co. updated its FY 2019 earnings guidance on Tuesday, July, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $19.0886192-19.8299248 billion, compared to the consensus revenue estimate of $19.22 billion.
What price target have analysts set for FMS?
9 analysts have issued 1-year price targets for Fresenius Medical Care AG & Co.'s shares. Their predictions range from $40.23 to $82.00. On average, they anticipate Fresenius Medical Care AG & Co.'s share price to reach $56.06 in the next year. This suggests a possible upside of 74.0% from the stock's current price. View Analyst Price Targets for Fresenius Medical Care AG & Co..
What is the consensus analysts' recommendation for Fresenius Medical Care AG & Co.?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Fresenius Medical Care AG & Co..
Has Fresenius Medical Care AG & Co. been receiving favorable news coverage?
Media coverage about FMS stock has trended negative this week, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Fresenius Medical Care AG & Co. earned a media sentiment score of -2.5 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Fresenius Medical Care AG & Co..
Who are some of Fresenius Medical Care AG & Co.'s key competitors?
What other stocks do shareholders of Fresenius Medical Care AG & Co. own?
Who are Fresenius Medical Care AG & Co.'s key executives?
Fresenius Medical Care AG & Co.'s management team includes the folowing people:
- Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)
- Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)
- Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)
- Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)
- Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57)
Who are Fresenius Medical Care AG & Co.'s major shareholders?
Fresenius Medical Care AG & Co.'s stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.01%), Crossmark Global Holdings Inc. (0.01%), Confluence Investment Management LLC (0.00%), Hartwell J M Limited Partnership (0.00%), Pacer Advisors Inc. (0.00%) and World Asset Management Inc (0.00%).
Which major investors are selling Fresenius Medical Care AG & Co. stock?
FMS stock was sold by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., Envestnet Asset Management Inc., Pacer Advisors Inc., Hartwell J M Limited Partnership, World Asset Management Inc, Confluence Investment Management LLC and Landsberg Bennett & Dubbaneh LLC.
Which major investors are buying Fresenius Medical Care AG & Co. stock?
FMS stock was bought by a variety of institutional investors in the last quarter, including Whittier Trust Co., Old North State Trust LLC and OLD National Bancorp IN.
How do I buy shares of Fresenius Medical Care AG & Co.?
Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Fresenius Medical Care AG & Co.'s stock price today?
One share of FMS stock can currently be purchased for approximately $32.21.
How big of a company is Fresenius Medical Care AG & Co.?
Fresenius Medical Care AG & Co. has a market capitalization of $19.51 billion and generates $19.44 billion in revenue each year. The company earns $2.34 billion in net income (profit) each year or $2.27 on an earnings per share basis. Fresenius Medical Care AG & Co. employs 112,658 workers across the globe.View Additional Information About Fresenius Medical Care AG & Co..
What is Fresenius Medical Care AG & Co.'s official website?
How can I contact Fresenius Medical Care AG & Co.?
Fresenius Medical Care AG & Co.'s mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-608-2522 or via email at [email protected]
MarketBeat Community Rating for Fresenius Medical Care AG & Co. (NYSE FMS)
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. and other stocks. Vote "Outperform" if you believe FMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
